Quixant (QXT) Share Price, News & Analysis

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Quixant in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" QXT shares.
View QXT analyst ratings or view top-rated stocks.

1 brokerages have issued 12 month target prices for Quixant's stock. Their QXT share price targets range from GBX 275 to GBX 275. On average, they predict the company's share price to reach GBX 275 in the next twelve months. This suggests a possible upside of 57.1% from the stock's current price.
View analysts price targets for QXT or view top-rated stocks among Wall Street analysts.

Quixant's stock was trading at GBX 175 at the beginning of the year. Since then, QXT stock has increased by 0.0% and is now trading at GBX 175.
View the best growth stocks for 2024 here.

Quixant (LON:QXT) pays an annual dividend of GBX 3 per share and currently has a dividend yield of 1.71%. The dividend payout ratio is 2,307.69%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for QXT.

Based on aggregate information from My MarketBeat watchlists, some companies that other Quixant investors own include Abeona Therapeutics (ABEO), American Public Education (APEI), Amgen (AMGN), Affiliated Managers Group (AMG), Akamai Technologies (AKAM), AGF Management (AGF.B), Strat Aero (AERO), Adobe (ADBE) and Accenture (ACN).

Shares of QXT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.